Literature DB >> 3361504

Functional aspects of peritoneal macrophages in endometriosis of women.

G A Dunselman1, M G Hendrix, P X Bouckaert, J L Evers.   

Abstract

Peritoneal fluid was collected in the periovulatory phase of the cycle from 25 women undergoing laparoscopy. Endometriosis was diagnosed in 13 patients (AFS score 1, N = 9; AFS score 2, N = 4) and 12 patients without endometriosis served as controls. In endometriosis patients the total peritoneal fluid cell number and cell concentration was significantly higher than in controls, indicating peritoneal irritation by endometrial implants. Peritoneal fluid macrophages in patients with endometriosis showed significantly increased erythrophagocytosis and lower chemiluminescence than in controls, suggesting an advanced differentiation of the macrophages in endometriosis patients. The macrophages in this stage of differentiation may interfere with gametes and embryos and thus contribute to endometriosis-associated subfertility.

Entities:  

Mesh:

Year:  1988        PMID: 3361504     DOI: 10.1530/jrf.0.0820707

Source DB:  PubMed          Journal:  J Reprod Fertil        ISSN: 0022-4251


  10 in total

1.  Endometriotic Epithelial Cell Response to Macrophage-Secreted Factors is Dependent on Extracellular Matrix Context.

Authors:  Kathryn Pollock; Taylor J Jaraczewski; Molly J Carroll; Dan I Lebovic; Pamela K Kreeger
Journal:  Cell Mol Bioeng       Date:  2014-06-06       Impact factor: 2.321

2.  Suppression of matrix metalloproteinase-9 by prostaglandin E(2) in peritoneal macrophage is associated with severity of endometriosis.

Authors:  Meng-Hsing Wu; Yutaka Shoji; Meng-Chi Wu; Pei-Chin Chuang; Chen-Chung Lin; Mei-Feng Huang; Shaw-Jenq Tsai
Journal:  Am J Pathol       Date:  2005-10       Impact factor: 4.307

3.  Outcome of IVF in patients with endometriosis in comparison with tubal-factor infertility.

Authors:  A Bergendal; S Naffah; C Nagy; A Bergqvist; P Sjöblom; T Hillensjö
Journal:  J Assist Reprod Genet       Date:  1998-10       Impact factor: 3.412

4.  Inhibition of CD36-dependent phagocytosis by prostaglandin E2 contributes to the development of endometriosis.

Authors:  Pei-Chin Chuang; Yiu-Juian Lin; Meng-Hsing Wu; Lih-Yuh C Wing; Yutaka Shoji; Shaw-Jenq Tsai
Journal:  Am J Pathol       Date:  2009-12-24       Impact factor: 4.307

5.  C-reactive protein of serum and peritoneal fluid in endometriosis.

Authors:  Maryam Kianpour; Mehdi Nematbakhsh; Sayad Mehdi Ahmadi
Journal:  Iran J Nurs Midwifery Res       Date:  2012-02

6.  Apoptosis induction of human endometriotic epithelial and stromal cells by noscapine.

Authors:  Mohammad Rasoul Khazaei; Zahra Rashidi; Farzaneh Chobsaz; Mozafar Khazaei
Journal:  Iran J Basic Med Sci       Date:  2016-09       Impact factor: 2.699

7.  Niclosamide As a Potential Nonsteroidal Therapy for Endometriosis That Preserves Reproductive Function in an Experimental Mouse Model.

Authors:  Genna R Prather; James A MacLean; Mingxin Shi; Daniel K Boadu; Marilène Paquet; Kanako Hayashi
Journal:  Biol Reprod       Date:  2016-08-17       Impact factor: 4.285

8.  Circulating IGF-binding protein 7 (IGFBP7) levels are elevated in patients with endometriosis or undergoing diabetic hemodialysis.

Authors:  Masahiko Kutsukake; Ryosuke Ishihara; Katsutoshi Momose; Keiichi Isaka; Osamu Itokazu; Chinatsu Higuma; Takeshi Matsutani; Akihisa Matsuda; Koji Sasajima; Takahiko Hara; Kazuhiro Tamura
Journal:  Reprod Biol Endocrinol       Date:  2008-11-19       Impact factor: 5.211

9.  Asymmetric dimethylarginine (ADMA), nitric oxide metabolite, and estradiol levels in serum and peritoneal fluid in women with endometriosis.

Authors:  Maryam Kianpour; Mehdi Nematbakhsh; Sayad Mehdi Ahmadi
Journal:  Iran J Nurs Midwifery Res       Date:  2015 Jul-Aug

10.  Lipoxin A₄ prevents the progression of de novo and established endometriosis in a mouse model by attenuating prostaglandin E₂ production and estrogen signaling.

Authors:  Rajesh Kumar; Anne-Catherine Clerc; Ilaria Gori; Ronan Russell; Chiara Pellegrini; Lerisa Govender; Jean-Christophe Wyss; Dela Golshayan; Geraldine O Canny
Journal:  PLoS One       Date:  2014-02-24       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.